4//SEC Filing
Blome James 4
Accession 0001127602-19-013430
CIK 0001705843other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:22 PM ET
Size
10.1 KB
Accession
0001127602-19-013430
Insider Transaction Report
Form 4
Calyxt, Inc.CLXT
Blome James
Chief Executive Officer
Transactions
- Sale
Restricted Stock Units
2019-03-26$17.87/sh−2,582$46,129→ 156,718 total
Footnotes (3)
- [F1]The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2019.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.64 to $18.09, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
Documents
Issuer
Calyxt, Inc.
CIK 0001705843
Entity typeother
Related Parties
1- filerCIK 0001753563
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 4:22 PM ET
- Size
- 10.1 KB